O
Oncozenge AB
F:8LY
Oncozenge AB
F:8LY
Price:
0.661
EUR
3.93%
Market Closed
Market Cap:
€7.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oncozenge AB
F:8LY
|
SE |
Income Statement
Earnings Waterfall
Oncozenge AB
Oncozenge AB
Income Statement
Oncozenge AB
Oncozenge AB
Currency: SEK
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
3
N/A
|
3
N/A
|
3
-2%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
(13)
|
(16)
|
(18)
|
(7)
|
(8)
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(11)
N/A
|
(13)
-16%
|
(16)
-26%
|
(18)
-8%
|
(7)
+63%
|
(6)
+13%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(5)
|
(36)
|
(38)
|
(40)
|
(44)
|
(15)
|
(16)
|
(17)
|
(5)
|
(1)
|
2
|
6
|
(2)
|
(3)
|
(10)
|
(11)
|
(18)
|
|
| Selling, General & Administrative |
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(5)
|
(9)
|
(9)
|
(7)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| R&D |
(0)
|
(32)
|
(33)
|
(35)
|
(38)
|
(9)
|
(11)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(3)
|
0
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
8
|
13
|
13
|
(0)
|
0
|
(4)
|
(5)
|
(15)
|
|
| Operating Income |
(5)
N/A
|
(36)
-645%
|
(38)
-5%
|
(40)
-6%
|
(44)
-8%
|
(15)
+66%
|
(16)
-11%
|
(17)
-6%
|
(16)
+8%
|
(14)
+11%
|
(14)
+0%
|
(12)
+17%
|
(9)
+26%
|
(9)
+1%
|
(7)
+21%
|
(9)
-25%
|
(16)
-85%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(5)
N/A
|
(36)
-645%
|
(38)
-5%
|
(40)
-6%
|
(44)
-8%
|
(15)
+66%
|
(16)
-11%
|
(17)
-6%
|
(16)
+8%
|
(14)
+11%
|
(14)
+0%
|
(12)
+17%
|
(9)
+26%
|
(9)
+1%
|
(7)
+21%
|
(9)
-25%
|
(16)
-86%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
1
|
(2)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(39)
|
(41)
|
(43)
|
(47)
|
(15)
|
(16)
|
(17)
|
(16)
|
(14)
|
(14)
|
(12)
|
(9)
|
(9)
|
(7)
|
(9)
|
(16)
|
|
| Net Income |
(4)
N/A
|
(39)
-902%
|
(41)
-5%
|
(43)
-6%
|
(47)
-8%
|
(15)
+69%
|
(16)
-11%
|
(17)
-6%
|
(16)
+8%
|
(14)
+11%
|
(14)
+0%
|
(12)
+17%
|
(9)
+26%
|
(9)
+1%
|
(7)
+21%
|
(9)
-25%
|
(16)
-86%
|
|
| EPS (Diluted) |
-0.33
N/A
|
-3.33
-909%
|
-3.48
-5%
|
-3.69
-6%
|
-3.98
-8%
|
-1.25
+69%
|
-1.39
-11%
|
-1.48
-6%
|
-1.36
+8%
|
-1.21
+11%
|
-1.21
N/A
|
-1
+17%
|
-0.74
+26%
|
-0.74
N/A
|
-0.58
+22%
|
-0.68
-17%
|
-1.31
-93%
|
|
Switch to:
Switch to:
Continue 8LY Research
Other Oncozenge AB listings:
Discover More
